EUVIMEDEUVIMED entdecken
Crossref

Antimicrobial resistance in Escherichia coli urinary isolates from primary care in Galicia (Spain), 2023–2024: Trends and relationship with antibiotic consumption

Isabel Losada-Castillo, Isolina Santiago-Pérez, Ana Isabel García-Vallejo, Lucía Martinez-Lamas, María Dolores Formoso Lavandeira, Raquel Vázquez-Mourelle

Enfermedades Infecciosas y Microbiología Clínica · 2026-11 · 44 (9) · 503264

DOI: 10.1016/j.eimc.2026.503264 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Enfermedades Infecciosas y Microbiología Clínica, 2026-11. Verfasst von Isabel Losada-Castillo und 5 weiteren Autor:innen. Die Arbeit nennt 31 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION The objective of this study was to describe antimicrobial resistance patterns of Escherichia coli isolated from urine samples in primary care and to identify trends relevant to empirical treatment of urinary tract infections. METHODS We conducted an observational, retrospective, multicenter study including 49,746 E. coli isolates from urine samples obtained between January 2023 and December 2024 in ten hospital microbiology laboratories in Galicia, Spain. Antimicrobial susceptibility testing followed EUCAST guidelines. Resistance rates were analyzed by age, sex, and temporal trends. Outpatient antibiotic consumption data from the Galician Health Service (2015-2024) were reviewed to correlate associations with resistance patterns. RESULTS E. coli was more frequently isolated in women, with higher rates in older adults. Resistance to amoxicillin-clavulanic acid increased compared with 2016-2017, whereas resistance to ciprofloxacin and trimethoprim-sulfamethoxazole declined. Fosfomycin resistance remained stable, and nitrofurantoin resistance appeared lower, likely reflecting updated breakpoints. Multidrug resistance was uncommon (3.37% for cefotaxime+ciprofloxacin+trimethoprim-sulfamethoxazole; 1% for cefotaxime+ciprofloxacin+trimethoprim-sulfamethoxazole+gentamicin). In two hospitals, ESBL-producing isolates showed significantly higher resistance to fosfomycin (p

Zitieren

APA

Losada-Castillo, I., Santiago-Pérez, I., García-Vallejo, A. I., Martinez-Lamas, L., Lavandeira, M. D. F., & Vázquez-Mourelle, R. (2026). Antimicrobial resistance in Escherichia coli urinary isolates from primary care in Galicia (Spain), 2023–2024: Trends and relationship with antibiotic consumption. Enfermedades Infecciosas y Microbiología Clínica, 44(9), 503264. https://doi.org/10.1016/j.eimc.2026.503264

Vancouver

Losada-Castillo I, Santiago-Pérez I, García-Vallejo AI, Martinez-Lamas L, Lavandeira MDF, Vázquez-Mourelle R. Antimicrobial resistance in Escherichia coli urinary isolates from primary care in Galicia (Spain), 2023–2024: Trends and relationship with antibiotic consumption. Enfermedades Infecciosas y Microbiología Clínica. 2026;44(9):503264. doi:10.1016/j.eimc.2026.503264

BibTeX
@article{LosadaCastillo2026,
  author = {Losada-Castillo, Isabel and Santiago-Pérez, Isolina and García-Vallejo, Ana Isabel and Martinez-Lamas, Lucía and Lavandeira, María Dolores Formoso and Vázquez-Mourelle, Raquel},
  title = {Antimicrobial resistance in Escherichia coli urinary isolates from primary care in Galicia (Spain), 2023–2024: Trends and relationship with antibiotic consumption},
  journal = {Enfermedades Infecciosas y Microbiología Clínica},
  year = {2026},
  volume = {44},
  number = {9},
  pages = {503264},
  doi = {10.1016/j.eimc.2026.503264}
}
Kostenlos starten →